Debt-to-equity of Structure Therapeutics Inc. from 30 Sep 2023 to 31 Dec 2025
- Taxonomy & unit
- ratio: x
- Description
- Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's debt by its shareholder equity.
- Summary
-
Structure Therapeutics Inc. quarterly Debt-to-equity in x history and change rate from 30 Sep 2023 to 31 Dec 2025.
- Structure Therapeutics Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was 0.06x, a 35% increase year-over-year.
Debt-to-equity, Quarterly (x)
Debt-to-equity, YoY Quarterly Change (%)
Structure Therapeutics Inc. Quarterly Debt-to-equity (x)
| Period | Value | YoY Chg | Change % | Date |
|---|---|---|---|---|
| Q4 2025 | 0.06x | +0.01x | +35% | 31 Dec 2025 |
| Q3 2025 | 0.06x | +0.01x | +31% | 30 Sep 2025 |
| Q2 2025 | 0.05x | -0.01x | -9.5% | 30 Jun 2025 |
| Q1 2025 | 0.04x | -0.03x | -45% | 31 Mar 2025 |
| Q4 2024 | 0.04x | -0.03x | -42% | 31 Dec 2024 |
| Q3 2024 | 0.04x | -0.07x | -63% | 30 Sep 2024 |
| Q2 2024 | 0.05x | 30 Jun 2024 | ||
| Q1 2024 | 0.07x | 31 Mar 2024 | ||
| Q4 2023 | 0.07x | 31 Dec 2023 | ||
| Q3 2023 | 0.12x | 30 Sep 2023 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.